Replies to post #473786 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

NWBO has not even updated the trial on clinicaltrials.gov.

It is pretty hard to argue the journalists are working with the wrong endpoints when they have not been officially changed.

We can argue that because we know about the endpoint change in Europe etc. but now you’re asking a modern journalist to do actual research and we know how that goes.

A lot of shareholders have been pointing out the issues with not doing basic updates like that but we’re ignored. Leaving outdated information out there has consequences.

[Hopeforthefuture3]

As shown on clinicaltrials.gov pfs is per the protocol listed the primary endpoint and they (AACE) perhaps the saw the presentation slide showing pfs failure and thus report trial failure. Yes reporter should have dug deeper but nwbo should have updated clinicaltrials.gov years ago and been prepared to defend trial results with a proper tld release. (Imo) nwbo needs to look in the mirror to see the real cause of the problem - management